Romidepsin enhances the efficacy of cytarabine in vivo, revealing histone deacetylase inhibition as a promising therapeutic strategy for KMT2A-rearranged infant acute lymphoblastic leukemia - Cheung, Laurence; Cruickshank, Mark N; Hughes, Anastasia M; Singh, Sajla; Chua, Grace-Alyssa; Ford, Jette; Ferrari, Emanuela; Oommen, Joyce; Malinge, Sébastien; Lock, Richard B; Kees, Ursula R; Kotecha, Rishi S (2019)